Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book focuses on fundamental and applied research on humoral immune responses to viral infections in humans. The comprehensive study of antibody response is critical for the development of diagnostic tools, vaccines, and immunotherapeutics against life-threatening viral infections. Special attention is given to serological surveillance and characterization of virus-neutralizing antibodies.

Medicine --- highly pathogenic avian influenza virus --- H5N6 (clade 2.3.4.4) --- human sera --- SARS-CoV-2 --- COVID-19 --- full proteome --- peptide microarrays --- glycan microarrays --- seroprevalence --- ELISA --- neutralization assay --- viral persistence --- serum antibody --- neutralization efficacy --- cytokine profile --- neutralising antibodies --- filoviruses --- ebolavirus --- post-vaccination --- post-infection --- monoclonal antibodies --- longitudinal antibody response --- antibody specificity --- recombinant proteins --- virus neutralization --- coronavirus disease 2019 --- Guangdong --- China --- antibody --- varicella–zoster virus (VZV) --- chemiluminescent immunoassay (CLIA) --- IgA --- IgG --- IgM --- diagnostic test --- antibody therapeutic --- cryo-EM --- filovirus --- marburgvirus --- structural biology --- X-ray crystallography --- n/a --- varicella-zoster virus (VZV)

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book focuses on fundamental and applied research on humoral immune responses to viral infections in humans. The comprehensive study of antibody response is critical for the development of diagnostic tools, vaccines, and immunotherapeutics against life-threatening viral infections. Special attention is given to serological surveillance and characterization of virus-neutralizing antibodies.

Medicine --- highly pathogenic avian influenza virus --- H5N6 (clade 2.3.4.4) --- human sera --- SARS-CoV-2 --- COVID-19 --- full proteome --- peptide microarrays --- glycan microarrays --- seroprevalence --- ELISA --- neutralization assay --- viral persistence --- serum antibody --- neutralization efficacy --- cytokine profile --- neutralising antibodies --- filoviruses --- ebolavirus --- post-vaccination --- post-infection --- monoclonal antibodies --- longitudinal antibody response --- antibody specificity --- recombinant proteins --- virus neutralization --- coronavirus disease 2019 --- Guangdong --- China --- antibody --- varicella-zoster virus (VZV) --- chemiluminescent immunoassay (CLIA) --- IgA --- IgG --- IgM --- diagnostic test --- antibody therapeutic --- cryo-EM --- filovirus --- marburgvirus --- structural biology --- X-ray crystallography --- highly pathogenic avian influenza virus --- H5N6 (clade 2.3.4.4) --- human sera --- SARS-CoV-2 --- COVID-19 --- full proteome --- peptide microarrays --- glycan microarrays --- seroprevalence --- ELISA --- neutralization assay --- viral persistence --- serum antibody --- neutralization efficacy --- cytokine profile --- neutralising antibodies --- filoviruses --- ebolavirus --- post-vaccination --- post-infection --- monoclonal antibodies --- longitudinal antibody response --- antibody specificity --- recombinant proteins --- virus neutralization --- coronavirus disease 2019 --- Guangdong --- China --- antibody --- varicella-zoster virus (VZV) --- chemiluminescent immunoassay (CLIA) --- IgA --- IgG --- IgM --- diagnostic test --- antibody therapeutic --- cryo-EM --- filovirus --- marburgvirus --- structural biology --- X-ray crystallography